CRISPR Therapeutics AG (the Company )Mandate Agreement • December 27th, 2019 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
The Parties take note that Dr. Rodger Novak (the Advisor) has been acting as the chairman of the Company’s board of directors (the Chairman and the Company’s board of directors the Board) since his election at the 2018 general meeting of shareholders of the Company. The Advisor has not received any remuneration for his services as Chairman so far.
Termination Agreement dated as of 27 December 2019 by and betweenTermination Agreement • December 27th, 2019 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
